uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Finally a promising analgesic signal in a long-awaited new class of drugs: TRPV1 antagonist mavatrep in patients with osteoarthritis (OA)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Anaesthesiology and Intensive Care.
2017 (English)In: Scandinavian Journal of Pain, ISSN 1877-8860, E-ISSN 1877-8879, Vol. 17, p. 154-155Article in journal, Editorial material (Other academic) Published
Place, publisher, year, edition, pages
Walter de Gruyter, 2017. Vol. 17, p. 154-155
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-349325DOI: 10.1016/j.sjpain.2017.08.015ISI: 000419851500025PubMedID: 28961519OAI: oai:DiVA.org:uu-349325DiVA, id: diva2:1201761
Available from: 2018-04-26 Created: 2018-04-26 Last updated: 2018-04-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Karlsten, Rolf

Search in DiVA

By author/editor
Karlsten, Rolf
By organisation
Anaesthesiology and Intensive Care
In the same journal
Scandinavian Journal of Pain
Neurology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 6 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf